Indisputable is ophthalmology’s vast role of providing not only comprehensive eye care to the populace but first-on-scene ...

Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ...

NYU Grossman’s Preeya Mehta, MD, and Jonathan S. Williams, MD, sit down with Mount Sinai’s Louis R. Pasquale, MD, to discuss long-term safety and efficacy data from a PreserFlo microshunt trial and ...

New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients treated ...

Opus Genetics, Inc. (Nasdaq: IRD) ('Opus Genetics” or the 'Company”), a clinical-stage biopharmaceutical company developing ...

Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate ...

Itchy, red and watery eyes are familiar symptoms for many people, especially during the spring and summer pollen season.

Almost one-third of physicians who are enrolled in Medicaid don't actually care for a single patient covered by Medicaid ...

TARRYTOWN, N.Y., Feb. 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: REGN) today announced upcoming presentations from its ophthalmology portfolio and pipeline at the virtual Angiogenesis (Angiogenesis, ...

The Paediatric Endocrinology Clinic of Kasturba Medical College and Hospital, Manipal, organised a day-long awareness and support programme for children with Type 1 Diabetes Mellitus (T1DM) and their ...

ZEISS Medical Technology announced today that China's National Medical Products Administration (NMPA) has approved the ZEISS ...

STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of ...